# FDA Inspection 1226719 - Shanghai Ziyuan Pharmaceutical Co., Ltd. - November 03, 2023

Source: https://www.keypedia.com/records/fda_inspections/shanghai-ziyuan-pharmaceutical-co-ltd/a195434c-b919-4932-a14d-2d13bcfa3a77
Source feed: FDA_Inspections

> FDA Inspection 1226719 for Shanghai Ziyuan Pharmaceutical Co., Ltd. on November 03, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226719
- Company Name: Shanghai Ziyuan Pharmaceutical Co., Ltd.
- Inspection Date: 2023-11-03
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 992542 - 2016-10-28](https://www.keypedia.com/records/fda_inspections/shanghai-ziyuan-pharmaceutical-co-ltd/57b924da-b3a6-440c-9696-058cc4a48a6e)
- [FDA Inspection 852897 - 2013-10-24](https://www.keypedia.com/records/fda_inspections/shanghai-ziyuan-pharmaceutical-co-ltd/22d83968-01e9-42a7-b13a-17f4e0c0f305)
- [FDA Inspection 741036 - 2011-06-23](https://www.keypedia.com/records/fda_inspections/shanghai-ziyuan-pharmaceutical-co-ltd/068dea4c-04c4-4cfe-affb-513195ad79b3)

Company: https://www.keypedia.com/companies/shanghai-ziyuan-pharmaceutical-co-ltd/d43e4356-b577-4912-8ef3-5772975f7de7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c